As expected, the volume of tumors arising from HT‐29/shPTPRK#2 cells was larger than that of HT‐29/pLKO cells (Fig. 1C), indicating that PTPRK gene silencing contributes to the tumor progression of colon cancer cells. The gene discussed is PTPRK; the disease is colonic neoplasm.